ARIAD Pharmaceuticals, Inc. has announced a non- exclusive worldwide license agreement with DiscoveRx Corporation that grants DiscoveRx the right to commercialize drug-discovery assay products covered by ARIAD’s pioneering NF-(kappa)B patents. DiscoveRx will pay ARIAD an upfront license fee and annual license fees, as well as royalties and milestones based on drug- discovery product sales. In Read more about ARIAD Licenses NF-(kappa)B Technology To DiscoveRx[…]